Research, News & Discoveries
-
David Cortez named chair of biochemistry
By: Wendy Bindeman David Cortez, Richard N. Armstrong, Ph.D. Chair for Innovation in Biochemistry and professor of biochemistry, has been appointed chair of the Department of Biochemistry beginning July 1, 2021. Cortez first joined the Department of Biochemistry in 2002 as an assistant professor, and became a professor of biochemistry… Read MoreJul. 16, 2021
-
Basic Sciences announces launch of new Extracellular Vesicle Research Center
By Lorena Infante Lara Beginning on July 1, the Program for Extracellular Vesicle Research got an upgrade and became one of the nine official centers and institutes associated with the School of Medicine Basic Sciences. The Center for Extracellular Vesicle Research will be led… Read MoreJul. 16, 2021
-
Ph.D. to CEO: Entrepreneurial Transformation with the ASPIRE to Innovate Postdoctoral Fellowship Program
By Ashley Brady A new collaborative initiative from the Vanderbilt University School of Medicine Basic Sciences, the BRET Office of Career Development’s ASPIRE Program, and Vanderbilt’s Center for Technology Transfer and Commercialization will be supporting a biomedical sciences postdoctoral fellow to lead a start-up company to… Read MoreJul. 13, 2021
-
Novel discovery describes how the motor cortex influences stress responses in brain regions involved in drug- and alcohol-seeking behavior
by Marissa Shapiro Jun. 24, 2021, 9:00 AM Series of de-lipidated (“cleared”) mouse brains imaged using light sheet microscopy to reveal neural circuits marked by viral tracing strategies. THE IDEA This may lead to collaboration to look for targets affecting the motor cortex and… Read MoreJun. 25, 2021
-
Combination antibody therapies should retain effectiveness against emerging COVID-19 variants: study
Jun. 22, 2021, 7:39 AM Five monoclonal antibody “cocktails,” including one developed at Vanderbilt University Medical Center (VUMC), are protective in animal studies against several variant strains of COVID-19, according to a report this week in the journal Nature. The findings suggest that many of the combination antibody therapies currently… Read MoreJun. 24, 2021
-
Merrikh named finalist for Blavatnik National Award for Young Scientists for second year
Jun. 17, 2021, 9:00 AM By Jenna Somers Houra Merrikh For the second year in a row, Professor of Biochemistry Houra Merrikh has been named a finalist for the 2021 Blavatnik National Awards for Young Scientists in the life sciences category for her discovery of a potential solution… Read MoreJun. 18, 2021
-
New neurodegeneration culprit
Jun. 17, 2021, 8:30 AM by Paul Govern Presented with the case of a young woman with a novel de novo genetic variant and a puzzling neurological illness, Eric Delpire, PhD, and colleagues saw aspects of the disease recapitulated in miniature when they used CRISPR to engineer the variant in mice. The team’s report, appearing… Read MoreJun. 18, 2021
-
Craig Lindsley named to Medicinal Chemistry Division of the American Chemical Society Hall of Fame
by Marissa Shapiro Jun. 15, 2021, 12:00 PM Craig Lindsley, the William K. Warren, Jr. Chair in Medicine and University Professor of Pharmacology, Biochemistry and Chemistry Craig Lindsley, the William K. Warren, Jr. Chair in Medicine and director of Vanderbilt University’s Warren… Read MoreJun. 16, 2021
-
Research Snapshot: Finding confirms process by which ketamine acts as an antidepressant
by Marissa Shapiro Jun. 10, 2021, 9:00 AM THE IDEA Lisa Monteggia, professor of pharmacology, and collaborators have provided evidence about how ketamine works as a rapid-acting antidepressant in the brain. The research reinforces the hypothesis that the glutamate N-methyl-D-aspartate (NMDA) receptor on… Read MoreJun. 11, 2021
-
Team develops potential treatment for life-threatening microbial inflammation
Jun. 8, 2021, 9:53 AM From left, Taylor Smith, MS, Jacek Hawiger, MD, PhD, Jozef Zienkiewicz, PhD, and Yan Liu, MD, and colleagues developed a peptide that may protect against life-threatening microbial inflammation with underlying metabolic syndrome. Photo courtesy Hawiger lab A cell-penetrating peptide developed by researchers at Vanderbilt University… Read MoreJun. 11, 2021